Lavender Bina Cendikia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Lavender Bina Cendikia Tbk. trades at Rp30 (market cap 30.9B, 2.96M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 18.9× Lavender Bina Cendikia Tbk.'s market cap, and Lavender Bina Cendikia Tbk. is more actively traded (2.96M versus 817.3K). Which is the better fit depends on your goals.
| BMBL | LABS | |
|---|---|---|
Market Cap | 30.9B | 584.6B |
Volume | 2.96M | 817.3K |
Lot | 29.64K | 8.17K |
Turnover | 88.75M | 120.01M |
Average Price | 29.94 | 146.84 |
Value | 88.75M | 120.01M |
Indicative Equilibrium Price | 30 | 146 |
Indicative Equilibrium Volume | 1 | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lavender Bina Cendikia Tbk ("Company") was established on November 27, 2013 based on theNotarial deed of Suparman Hasyim, S.H., No. 35. The Company started its commercial operations in2013. The ultimate beneficial owner of the Company is Galih Pandekar.
Read more on BMBL →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →